Sweden
· Delayed Price · Currency is SEK Level Bio AB Statistics
Total Valuation
Level Bio AB has a market cap or net worth of SEK 17.44 million. The enterprise value is 16.10 million.
| Market Cap | 17.44M |
| Enterprise Value | 16.10M |
Important Dates
The next estimated earnings date is Wednesday, February 19, 2025.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Level Bio AB has 68.40 million shares outstanding. The number of shares has increased by 1.97% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 68.40M |
| Shares Change (YoY) | +1.97% |
| Shares Change (QoQ) | +8.12% |
| Owned by Insiders (%) | 15.39% |
| Owned by Institutions (%) | 13.19% |
| Float | 32.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.69 |
| PB Ratio | 3.15 |
| P/TBV Ratio | 9.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.50 |
| EV / Sales | 0.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.52 |
Financial Position
The company has a current ratio of 1.20
| Current Ratio | 1.20 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -126.80 |
Financial Efficiency
Return on equity (ROE) is -106.50% and return on invested capital (ROIC) is -67.27%.
| Return on Equity (ROE) | -106.50% |
| Return on Assets (ROA) | -37.14% |
| Return on Capital (ROIC) | -67.27% |
| Revenue Per Employee | 2.16M |
| Profits Per Employee | -978,728 |
| Employee Count | 13 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 2.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.95% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -42.95% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.33 |
| Relative Strength Index (RSI) | 45.63 |
| Average Volume (20 Days) | 54,237 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Level Bio AB had revenue of SEK 23.74 million and -10.77 million in losses. Loss per share was -0.17.
| Revenue | 23.74M |
| Gross Profit | 11.35M |
| Operating Income | -10.88M |
| Pretax Income | -10.95M |
| Net Income | -10.77M |
| EBITDA | -10.50M |
| EBIT | -10.88M |
| Loss Per Share | -0.17 |
Balance Sheet
| Cash & Cash Equivalents | 1.34M |
| Total Debt | n/a |
| Net Cash | 1.34M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 5.54M |
| Book Value Per Share | 0.08 |
| Working Capital | 1.86M |
Cash Flow
In the last 12 months, operating cash flow was -6.35 million and capital expenditures -42,500, giving a free cash flow of -6.39 million.
| Operating Cash Flow | -6.35M |
| Capital Expenditures | -42,500 |
| Free Cash Flow | -6.39M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 47.79%, with operating and profit margins of -45.82% and -45.35%.
| Gross Margin | 47.79% |
| Operating Margin | -45.82% |
| Pretax Margin | -46.13% |
| Profit Margin | -45.35% |
| EBITDA Margin | -44.22% |
| EBIT Margin | -45.82% |
| FCF Margin | n/a |
Dividends & Yields
Level Bio AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.97% |
| Shareholder Yield | -1.97% |
| Earnings Yield | -65.51% |
| FCF Yield | -36.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |